神经修復术市场规模、份额、成长分析，按类型、技术、应用、地区划分 - 产业预测，2024-2031 年

Neuroprosthetics Market Size, Share, Growth Analysis, By Type, By Technique, By Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年10月06日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球神经修復市场规模为103亿美元，从2023年的115.9亿美元成长到2031年的297.3亿美元，复合年增长率预计为12.50%。

神经系统疾病盛行率的上升以及对具有成本效益和技术先进的植入的需求不断增长预计将在未来几年推动全球神经假体市场的成长。此外，老年人口的增加和听力障碍、癫痫、阿兹海默症和严重忧郁症等疾病发病率的增加进一步促进了市场的扩张。随着对改进治疗的需求增加，预计全球对神经修復解决方案的需求将会增加。听力损失病例的显着增加也在市场成长中发挥重要作用。助听器和人工电子耳等设备对于解决这些问题至关重要。根据世界卫生组织（WHO）预测，到2031年，全球将有约25亿人遭受听力损失，约7亿人需要听力復健。听力损失负担的增加可能会在不久的将来进一步推动对神经修復术的需求。此外，领先公司和政府机构增加对技术进步和研发的投资也有望促进市场成长。例如，2019 年 8 月，MED-EL 的 Synchrony-2人工电子耳系统获得美国食品药物管理局的核准，该系统专为单侧和不对称听力损失患者设计，显示了该领域的持续创新。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Medtronic（US）
Abbott（US）
Cochlear（Australia）
Boston Scientific（US）
Livanova（UK）
Med-El（Austria）
Sonova（Switzerland）
Neuropace（US）
NDI Medical（Canada）
Nevro（US）
SensArs Neuroprosthetics（Switzerland）
NeuroPace, Inc.（US）
Pixium Vision（France）
NeuroSigma, Inc.（US）
Axonics Modulation Technologies, Inc.（US）
Nervo Corp（US）
Soterix Medical, Inc.（US）
Aleva Neurotherapeutics SA（Switzerland）
Synapse Biomedical, Inc.（US）
Cleveland FES Center（US）

简介目录

Product Code: SQMIG35A2517

Global Neuroprosthetics Market size was valued at USD 10.3 billion in 2022 and is poised to grow from USD 11.59 billion in 2023 to USD 29.73 billion by 2031, growing at a CAGR of 12.50% during the forecast period (2024-2031).

The rising prevalence of neurological disorders and the growing demand for cost-effective, technologically advanced implants are anticipated to drive the growth of the global neuroprosthetics market in the coming years. Additionally, the increasing geriatric population and the growing incidence of diseases such as auditory disorders, epilepsy, Alzheimer's, and severe depression are further contributing to the market's expansion. As the need for improved treatments grows, the demand for neuroprosthetic solutions is expected to rise globally. The significant increase in hearing loss cases also plays a key role in market growth. Devices like hearing aids and cochlear implants are crucial in addressing these issues. According to the World Health Organization, by 2031, approximately 2.5 billion people worldwide are projected to suffer from hearing loss, with around 700 million expected to require hearing rehabilitation. This growing burden of hearing impairment is likely to further boost demand for neuroprosthetics in the near future. Technological advancements and increased investment in research and development by major companies and government organizations are also expected to fuel market growth. For example, in August 2019, MED-EL received approval from the U.S. Food & Drug Administration for its Synchrony-2 Cochlear Implant System, designed for patients with single-sided deafness and asymmetric hearing loss, illustrating the continuous innovation driving the sector forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neuroprosthetics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neuroprosthetics Market Segmental Analysis

Global Neuroprosthetics Market is segmented by Type, Technique, Application, and region. Based on Type, the market is segmented into Output Neural Prosthetics, Neural Prosthetic. Based on Technique, the market is segmented into Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Transcranial Magnetic Stimulation. Based on Application, the market is segmented into Motor Neuron Disorders, Physiological Disorders, and Cognitive Disorders. Based on end user, the market is segmented into automotive, consumer electronics, healthcare, agriculture, manufacturing, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Neuroprosthetics Market

The high prevalence of neurological disorders and nerve-related injuries is expected to be a significant driver for the global neuroprosthetics market during the forecast period. For instance, neurological diseases have led to more than 533,000 deaths, with around 213,000 males and 320,000 females affected. Neuroprosthetic devices offer numerous benefits, making them essential in the treatment of such conditions. These devices, such as cochlear implants and auditory brainstem implants (ABI), are particularly beneficial for patients with hearing impairments. As a result, the global demand for neuroprosthetics in diagnosing and treating various neurological disorders is expected to fuel market growth in the coming years. The increasing recognition of the advantages of these devices in improving patient outcomes will likely lead to greater adoption, further propelling the market's expansion.

Restraints in the Global Neuroprosthetics Market

The growing popularity of alternative treatment methods, such as stem cell therapy, is expected to significantly hamper the growth of the neuroprosthetics market during the forecast period. Stem cell therapy provides promising opportunities for treating various neurological conditions, including motor neuron diseases like Parkinson's and Alzheimer's. Its appeal lies in its relatively lower cost compared to neuroprosthetic devices, as well as the simplicity of its treatment regimen, which is attracting more patients toward this alternative option. As a result, the increasing shift toward stem cell treatments is likely to restrain the global expansion of the neuroprosthetics market in the coming years, as patients opt for these cost-effective and less invasive alternatives.

Market Trends of the Global Neuroprosthetics Market

Input neural prosthetics are gaining increasing popularity due to the rising prevalence of hearing loss and technological advancements in the development of various devices. These prosthetics offer significant benefits, such as restoring a sense of sound for individuals who are profoundly deaf or hard of hearing. Their ease of use and relatively low implementation cost make them attractive, creating substantial growth opportunities in the coming years. Research indicates that cochlear implants not only help diagnose hearing loss but are also being recommended as a rehabilitation tool for tinnitus patients suffering from depression. As a result, the neuroprosthetics market is poised for significant growth in the near future, driven by the growing demand for innovative solutions to address hearing loss and other related conditions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Regulatory Analysis
Case Study Analysis

Neuroprosthetics Market by Type

Market Overview
Output Neural Prosthetics
- Motor Prosthetics
- Cognitive Prosthetics
Input Neural Prosthetics
- Cochlear Implants
- Bionic Eye/Retinal Implants

Neuroprosthetics Market by Technique

Market Overview
Spinal Cord Stimulation
Deep Brain Stimulation
Vagus Nerve Stimulation
Sacral Nerve Stimulation
Transcranial Magnetic Stimulation

Neuroprosthetics Market by Application

Market Overview
Motor Neuron Disorders
- Parkinson'S Disease
- Epilepsy
Physiological Disorders
- Auditory Processing Disorders
- Ophthalmic Disorders
- Cardiovascular Disorders
- Urology Disorders
Cognitive Disorders
- Alzheimer'S Disease
- Paralysis

Neuroprosthetics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cochlear (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Livanova (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Med-El (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonova (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuropace (U S)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NDI Medical (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SensArs Neuroprosthetics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroPace, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pixium Vision (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroSigma, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Axonics Modulation Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nervo Corp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soterix Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleva Neurotherapeutics SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synapse Biomedical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cleveland FES Center (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments